Co-regulation analysis of closely linked genes identifies a highly recurrent gain on chromosome 17q25.3 in prostate cancer

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Bermudo, Raquel ^a,b   Abia, David ^c   Ferrer, Berta ^d   Nayach, Iracema ^d   Benguria, Alberto ^c,f   Zaballos, Ángel ^c   del Rey, Javier ^e   Miró, Rosa ^e   Campo, Elías ^b,d   Martínez A, Carlos ^c   Ortiz, Ángel R ^c   Fernández, Pedro L ^b,d   Thomson, Timothy M ^a  

^a INSTITUT DE BIOLOGIA MOLECULAR DE BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^f CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 17Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; COMPUTER ANALYSIS; COMPUTER MODEL; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC LINKAGE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOME ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE CANCER; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE CHARACTERIZATION; VALIDATION PROCESS; ADENOCARCINOMA; CHROMOSOME 17; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEIC ACID HYBRIDIZATION; PROSTATE TUMOR; TUMOR CELL LINE;

ADENOCARCINOMA; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 17; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; NUCLEIC ACID HYBRIDIZATION; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 56849118172     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-315     Document Type: Article

References (44)

1. LaTulippe E Satagopan J Smith A Scher H Scardino P Reuter V Gerald WL Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease Cancer Res 2002, 62:4499-4506 12154061
2. Ashida S Nakagawa H Katagiri T Furihata M Iiizumi M Anazawa Y Tsunoda T Takata R Kasahara K Miki T Fujioka T Shuin T Nakamura Y Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: Genome-wide gene-expression profiles of prostate cancers and PINs Cancer Res 2004, 64:5963-5972 10.1158/ 0008-5472.CAN-04-0020 15342375
3. Lapointe J Li C Higgins JP Rijn van de M Bair E Montgomery K Ferrari M Egevad L Rayford W Bergerheim U Ekman P DeMarzo AM Tibshirani R Botstein D Brown PO Brooks JD Pollack JR Gene expression profiling identifies clinically relevant subtypes of prostate cancer Proc Natl Acad Sci USA 2004, 101:811-816 321763 14711987 10.1073/pnas.0304146101
4. Singh D Febbo PG Ross K Jackson DG Manola J Ladd C Tamayo P Renshaw AA D'Amico AV Richie JP Lander ES Loda M Kantoff PW Golub TR Sellers WR Gene expression correlates of clinical prostate cancer behavior Cancer Cell 2002, 1:203-209 10.1016/S1535-6108(02)00030-2 12086878
5. Stuart RO Wachsman W Berry CC Wang-Rodriguez J Wasserman L Klacansky I Masys D Arden K Goodison S McClelland M Wang Y Sawyers A Kalcheva I Tarin D Mercola D In silico dissection of cell-type-associated patterns of gene expression in prostate cancer Proc Natl Acad Sci USA 2004, 101:615-620 327196 14722351 10.1073/pnas.2536479100
6. Ernst T Hergenhahn M Kenzelmann M Cohen CD Bonrouhi M Weninger A Klaren R Grone EF Wiesel M Gudemann C Kuster J Schott W Staehler G Kretzler M Hollstein M Grone HJ Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: A gene expression analysis on total and microdissected prostate tissue Am J Pathol 2002, 160:2169-2180 1850818 12057920
7. Chen Z Trotman LC Shaffer D Lin HK Dotan ZA Niki M Koutcher JA Scher HI Ludwig T Gerald W Cordon-Cardo C Pandolfi PP Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis Nature 2005, 436:725-730 1939938 16079851 10.1038/ nature03918
8. Tomlins SA Rhodes DR Perner S Dhanasekaran SM Mehra R Sun XW Varambally S Cao X Tchinda J Kuefer R Lee C Montie JE Shah RB Pienta KJ Rubin MA Chinnaiyan AM Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer Science 2005, 310:644-648 10.1126/ science.1117679 16254181
9. Eeles RA Kote-Jarai Z Giles GG Olama AA Guy M Jugurnauth SK Mulholland S Leongamornlert DA Edwards SM Morrison J Field HI Southey MC Severi G Donovan JL Hamdy FC Dearnaley DP Muir KR Smith C Bagnato M Ardern-Jones AT Hall AL O'Brien LT Gehr-Swain BN Wilkinson RA Cox A Lewis S Brown PM Jhavar SG Tymrakiewicz M Lophatananon A Bryant SL Horwich A Huddart RA Khoo VS Parker CC Woodhouse CJ Thompson A Christmas T Ogden C Fisher C Jamieson C Cooper CS English DR Hopper JL Neal DE Easton DF Multiple newly identified loci associated with prostate cancer susceptibility Nat Genet 2008, 40:316-321 10.1038/ng.90 18264097
10. Zheng SL Sun J Wiklund F Smith S Stattin P Li G Adami HO Hsu FC Zhu Y Balter K Kader AK Turner AR Liu W Bleecker ER Meyers DA Duggan D Carpten JD Chang BL Isaacs WB Xu J Gronberg H Cumulative association of five genetic variants with prostate cancer The New Engl J Med 2008, 358:910-919 18199855 10.1056/NEJMoa075819
11. Thomas G Jacobs KB Yeager M Kraft P Wacholder S Orr N Yu K Chatterjee N Welch R Hutchinson A Crenshaw A Cancel-Tassin G Staats BJ Wang Z Gonzalez-Bosquet J Fang J Deng X Berndt SI Calle EE Feigelson HS Thun MJ Rodriguez C Albanes D Virtamo J Weinstein S Schumacher FR Giovannucci E Willett WC Cussenot O Valeri A Andriole GL Crawford ED Tucker M Gerhard DS Fraumeni JF Jr Hoover R Hayes RB Hunter DJ Chanock SJ Multiple loci identified in a genome-wide association study of prostate cancer Nat Genet 2008, 40:310-315 10.1038/ng.91 18264096
12. Irizarry RA Hobbs B Collin F Beazer-Barclay YD Antonellis KJ Scherf U Speed TP Exploration, normalization, and summaries of high density oligonucleotide array probe level data Biostatistics 2003, 4:249-264 10.1093/biostatistics/4.2.249 12925520
13. Bolstad BM Irizarry RA Astrand M Speed TP A comparison of normalization methods for high density oligonucleotide array data based on variance and bias Bioinformatics 2003, 19:185-193 10.1093/bioinformatics/19.2.185 12538238
14. Lozano JJ Soler M Bermudo R Abia D Fernandez PL Thomson TM Ortiz AR Dual activation of pathways regulated by steroid receptors and peptide growth factors in primary prostate cancer revealed by Factor Analysis of microarray data BMC Genomics 2005, 6:109 1239914 16107210 10.1186/ 1471-2164-6-109
15. Benjamini Y Hochberg Y Controlling the False Discovery Rate - a practical and powerful approach to multiple testing Journal of the Royal Statistical Society Series B-Methodological 1995, 57:289-300
16. Sneath P Sokal R Numerical taxonomy: The principles and practice of numerical classification San Francisco: W.H. Freeman 1973
17. Deutsch EW Ball CA Berman JJ Bova GS Brazma A Bumgarner RE Campbell D Causton HC Christiansen JH Daian F Dauga D Davidson DR Gimenez G Goo YA Grimmond S Henrich T Herrmann BG Johnson MH Korb M Mills JC Oudes AJ Parkinson HE Pascal LE Pollet N Quackenbush J Ramialison M Ringwald M Salgado D Sansone SA Sherlock G Stoeckert CJ Jr Swedlow J Taylor RC Walashek L Warford A Wilkinson DG Zhou Y Zon LI Liu AY True LD Minimum information specification for in situ hybridization and immunohistochemistry experiments (MISFISHIE) Nat Biotechnol 2008, 26:305-312 10.1038/nbt1391 18327244
18. Signoretti S Loda M Defining cell lineages in the prostate epithelium Cell Cycle 2006, 5:138-141 16357539
19. Schalken JA van Leenders G Cellular and molecular biology of the prostate: Stem cell biology Urology 2003, 62:11-20 10.1016/ S0090-4295(03)00758-1 14607213
20. Xu J Stolk JA Zhang X Silva SJ Houghton RL Matsumura M Vedvick TS Leslie KB Badaro R Reed SG Identification of differentially expressed genes in human prostate cancer using subtraction and microarray Cancer Res 2000, 60:1677-1682 10749139
21. Dhanasekaran SM Barrette TR Ghosh D Shah R Varambally S Kurachi K Pienta KJ Rubin MA Chinnaiyan AM Delineation of prognostic biomarkers in prostate cancer Nature 2001, 412:822-826 10.1038/35090585 11518967
22. Magee JA Araki T Patil S Ehrig T True L Humphrey PA Catalona WJ Watson MA Milbrandt J Expression profiling reveals hepsin overexpression in prostate cancer Cancer Res 2001, 61:5692-5696 11479199
23. Yi Y Mirosevich J Shyr Y Matusik R George AL Jr Coupled analysis of gene expression and chromosomal location Genomics 2005, 85:401-412 10.1016/ j.ygeno.2004.11.011 15718107
24. Macintosh CA Stower M Reid N Maitland NJ Precise microdissection of human prostate cancers reveals genotypic heterogeneity Cancer Res 1998, 58:23-28 9426051
25. Deyoung MP Scheurle D Damania H Zylberberg C Narayanan R Down's syndrome-associated single minded gene as a novel tumor marker Anticancer Res 2002, 22:3149-3157 12530058
26. Went P Vasei M Bubendorf L Terracciano L Tornillo L Riede U Kononen J Simon R Sauter G Baeuerle PA Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers Br J Cancer 2006, 94:128-135 10.1038/sj.bjc.6602924 16404366
27. Lin H Chen MC Chiu CY Song YM Lin SY Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells The J Biol Chem 2007, 282:2776-2784 10.1074/jbc.M607234200
28. Cui J Rohr LR Swanson G Speights VO Maxwell T Brothman AR Hypermethylation of the caveolin-1 gene promoter in prostate cancer Prostate 2001, 46:249-256 10.1002/ 1097-0045(20010215)46:3<249::AID-PROS1030>3.0.CO;2-# 11170154
29. Chetcuti A Margan SH Russell P Mann S Millar DS Clark SJ Rogers J Handelsman DJ Dong Q Loss of annexin II heavy and light chains in prostate cancer and its precursors Cancer Res 2001, 61:6331-6334 11522620
30. Lee WH Isaacs WB Bova GS Nelson WG CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: A new prostate cancer biomarker Cancer Epidemiol Biomarkers Prev 1997, 6:443-450 9184779
31. Storlazzi CT Brekke HR Mandahl N Brosjo O Smeland S Lothe RA Mertens F Identification of a novel amplicon at distal 17q containing the BIRC5/ SURVIVIN gene in malignant peripheral nerve sheath tumours J Pathol 2006, 209:492-500 10.1002/path.1998 16721726
32. Shah US Dhir R Gollin SM Chandran UR Lewis D Acquafondata M Pflug BR Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma Hum Pathol 2006, 37:401-409 10.1016/j.humpath.2005.11.022 16564913
33. Greshock J Naylor TL Margolin A Diskin S Cleaver SH Futreal PA deJong PJ Zhao S Liebman M Weber BL 1-Mb resolution array-based comparative genomic hybridization using a BAC clone set optimized for cancer gene analysis Genome Res 2004, 14:179-187 314295 14672980 10.1101/gr.1847304
34. Malliri A Collard JG Role of Rho-family proteins in cell adhesion and cancer Curr Opin Cell Biol 2003, 15:583-589 10.1016/ S0955-0674(03)00098-X 14519393
35. Peters JM The anaphase promoting complex/cyclosome: A machine designed to destroy Nat Rev Mol Cell Biol 2006, 7:644-656 10.1038/nrm1988 16896351
36. Kataoka K Noda M Nishizawa M Transactivation activity of Maf nuclear oncoprotein is modulated by Jun, Fos and small Maf proteins Oncogene 1996, 12:53-62 8552399
37. Katsuoka F Motohashi H Engel JD Yamamoto M Nrf2 transcriptionally activates the mafG gene through an antioxidant response element J Biol Chem 2005, 280:4483-4490 10.1074/jbc.M411451200 15574414
38. Ladanyi M Lui MY Antonescu CR Krause-Boehm A Meindl A Argani P Healey JH Ueda T Yoshikawa H Meloni-Ehrig A Sorensen PH Mertens F Mandahl N Berghe van den H Sciot R Cin PD Bridge J The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25 Oncogene 2001, 20:48-57 10.1038/ sj.onc.1204074 11244503
39. Kuhajda FP Fatty acid synthase and cancer: New application of an old pathway Cancer Res 2006, 66:5977-5980 10.1158/0008-5472.CAN-05-4673 16778164
40. Walker-Daniels J Coffman K Azimi M Rhim JS Bostwick DG Snyder P Kerns BJ Waters DJ Kinch MS Overexpression of the EphA2 tyrosine kinase in prostate cancer Prostate 1999, 41:275-280 10.1002/ (SICI)1097-0045(19991201)41:4<275::AID-PROS8>3.0.CO;2-T 10544301
41. Saramaki OR Porkka KP Vessella RL Visakorpi T Genetic aberrations in prostate cancer by microarray analysis Int J Cancer 2006, 119:1322-1329 10.1002/ijc.21976 16642477
42. Alers JC Krijtenburg PJ Vis AN Hoedemaeker RF Wildhagen MF Hop WC Kwast van Der TT Schroder FH Tanke HJ van Dekken H Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies: Early cancers may contain aggressive genetic features Am J Pathol 2001, 158:399-406 1850287 11159178
43. Wolter H Gottfried HW Mattfeldt T Genetic changes in stage pT2N0 prostate cancer studied by comparative genomic hybridization BJU Int 2002, 89:310-316 10.1046/j.1464-4096.2001.01722.x 11856117
44. Wolter H Trijic D Gottfried HW Mattfeldt T Chromosomal changes in incidental prostatic carcinomas detected by comparative genomic hybridization Eur Urol 2002, 41:328-334 10.1016/S0302-2838(02)00035-0 12180237